₹38
▼ -0.05 -0.13%
17 Jul 2026
NSE Listed · Basic Materials
Vineet Laboratories Ltd. (VINEETLAB)
Volume: 1,347Avg Vol 1W: 70,533Avg Vol 1M: 23,76052W Range:₹24.45₹43.5
Key Ratios
Checked 2h agoMarket Cap₹73 Cr
Current Price₹38
Previous Close₹38.05
High / Low (52w)₹43.5 / ₹24.45
Volume1,347
Avg Vol (1W)70,533
Avg Vol (1M)23,760
Stock P/E—
Book Value₹23
Dividend Yield0%
ROE-117.41%
ROA-11.2%
Revenue (TTM)₹56 Cr
Revenue Growth—
Profit Margin-18.59%
Total Debt—
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹0
P/B1.65
Debt / Equity1.71
50 DMA₹34.07
200 DMA₹33.62
Day change-0.13%
Price Chart
₹38▲ 8.76% · 1Y
2025-11-212026-07-16
20-day avg volume: 26K shares
Pros
- Company is almost debt-free.
Cons
- Revenue fell 49% YoY.
- Company is loss-making at the latest annual result.
Quarterly Results
| Metric | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹37 Cr | ₹24 Cr | ₹19 Cr | ₹18 Cr | ₹14 Cr | ₹7 Cr | ₹17 Cr | ₹16 Cr |
| EBITDA | ₹3 Cr | ₹-1 Cr | ₹-1 Cr | ₹-5 Cr | ₹-10 Cr | ₹0 Cr | ₹3 Cr | ₹2 Cr |
| Net Profit | ₹2 Cr | ₹-2 Cr | ₹-2 Cr | ₹-6 Cr | ₹-11 Cr | ₹-1 Cr | ₹0 Cr | ₹1 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹244 Cr | ₹191 Cr | ₹212 Cr | ₹151 Cr | ₹77 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹7 Cr | ₹11 Cr | ₹5 Cr | ₹5 Cr | ₹-17 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹7 Cr | ₹1 Cr | ₹1 Cr | ₹-20 Cr |
| EPS | 0 | 0 | 2.18 | 7.16 | 1.36 | 1.11 | -21.9 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | ₹0 Cr | ₹0 Cr | ₹109 Cr | ₹133 Cr | ₹116 Cr | ₹117 Cr | ₹95 Cr |
| Total Liabilities | ₹0 Cr | ₹0 Cr | ₹82 Cr | ₹100 Cr | ₹82 Cr | ₹82 Cr | ₹80 Cr |
| Equity | ₹0 Cr | ₹0 Cr | ₹27 Cr | ₹33 Cr | ₹34 Cr | ₹35 Cr | ₹15 Cr |
| Total Debt | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹27 Cr | ₹11 Cr | ₹-7 Cr | ₹-6 Cr | ₹12 Cr |
| Investing | ₹-8 Cr | ₹-4 Cr | ₹-7 Cr | ₹-2 Cr | ₹-3 Cr |
| Financing | ₹19 Cr | ₹12 Cr | ₹0 Cr | ₹8 Cr | ₹-8 Cr |
| Free Cash Flow | ₹27 Cr | ₹11 Cr | ₹-7 Cr | ₹-6 Cr | ₹12 Cr |
Shareholding
Promoter 5.98% Institutions 0.36% Public 93.66%
About Vineet Laboratories Ltd.
Basic Materials · Chemicals
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.
vineetlabs.co.in ↗Efficiency & Working Capital
ROCE-22.4%
Interest Coverage-4.2
Dividend Payout—
Debtor Days64 d
Inventory Days243 d
Payable Days164 d
Cash Conversion Cycle144 d
Working Capital Days308 d
Shareholding Details
As of 2026-03-31
Promoter6%
FII0.4%
DII0%
Institutions0.4%
Public93.7%
Promoter Pledge0%
No. of Shareholders9,929
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Feb 2026 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 38.7% | 37.6% | 37.5% | 37.5% | 36.1% | 35.8% | 35.8% | 29.3% | 15.9% | 12.5% | 6% | 6% |
| FIIs | 0% | 0.2% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.4% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 61.3% | 62.2% | 62.5% | 62.5% | 63.9% | 64.2% | 64.2% | 70.7% | 84.1% | 87.5% | 94% | 93.7% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 9,469 | 9,514 | 9,638 | 9,523 | 10,300 | 10,058 | 10,025 | 9,988 | 9,682 | 10,003 | 10,042 | 9,929 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Arjun Aggarwal | Public Shareholding | 11.4% | 21,80,000 |
| Gaddam Venkata Ramana | Shareholding of Promoter and Promoter Group | 2.5% | 4,71,600 |
| Rajesh Poddar | Public Shareholding | 2.2% | 4,13,256 |
| Palloli Rama Chandra Reddy | Public Shareholding | 1.9% | 3,56,835 |
| Iswarya Gajjala | Public Shareholding | 1.6% | 3,12,100 |
| Sudha Madhu Sudhan Reddy | Public Shareholding | 1.6% | 3,09,753 |
| Anasuya Gorla | Public Shareholding | 1.6% | 3,02,529 |
| Manchuri Manohar Reddy | Public Shareholding | 1.6% | 3,00,892 |
| Rajendra Agrawal | Public Shareholding | 1.6% | 3,02,087 |
| Ajay Agrawal | Public Shareholding | 1.5% | 2,93,668 |
| Surekha Naga Lakshmi Pendela | Public Shareholding | 1.5% | 2,89,161 |
| Jyoti Agarwal | Public Shareholding | 1.4% | 2,66,212 |
| Madhu Nalajala | Public Shareholding | 1.3% | 2,55,141 |
| Venkata Sesha Reddy Mudimela | Public Shareholding | 1.2% | 2,33,891 |
| Satyanarayana Raju Bhupathiraju | Shareholding of Promoter and Promoter Group | 0.7% | 1,32,145 |
| A Prabhakar Raju | Shareholding of Promoter and Promoter Group | 0.5% | 95,476 |
| A Srinivasa Raju | Shareholding of Promoter and Promoter Group | 0.5% | 94,386 |
| A Ranga Raju | Shareholding of Promoter and Promoter Group | 0.4% | 74,243 |
| Alluri Anantha Laxmi | Shareholding of Promoter and Promoter Group | 0.3% | 65,641 |
| Alluri Mythili | Shareholding of Promoter and Promoter Group | 0.3% | 54,795 |
| Penmetsa Venkata Krishnam Raju | Shareholding of Promoter and Promoter Group | 0.3% | 47,988 |
| P Kishore Raju | Shareholding of Promoter and Promoter Group | 0.3% | 48,812 |
| Gaddam Srinivasarao | Shareholding of Promoter and Promoter Group | 0.2% | 36,232 |
| Gaddam Venkata Rama | Shareholding of Promoter and Promoter Group | 0.1% | 25,011 |
| V Varaprasada Rao | Shareholding of Promoter and Promoter Group | 0% | 1,030 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Satyanarayana Raju Bhupathiraju | 0 | 0% | 2026-03-31 |
| V Varaprasada Rao | 0 | 0% | 2026-03-31 |
| A Srinivasa Raju | 0 | 0% | 2026-03-31 |
| A Ranga Raju | 0 | 0% | 2026-03-31 |
| A Prabhakar Raju | 0 | 0% | 2026-03-31 |
| Alluri Mythili | 0 | 0% | 2026-03-31 |
| Gaddam Venkata Ramana | 0 | 0% | 2026-03-31 |
| Alluri Anantha Laxmi | 0 | 0% | 2026-03-31 |
| Gaddam Venkata Rama | 0 | 0% | 2026-03-31 |
| Kandula Murali Mohan | 0 | 0% | 2026-03-31 |
| Penmetsa Venkata Krishnam Raju | 0 | 0% | 2026-03-31 |
| P Kishore Raju | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Dilip V Acharekar | Chairman & Independent Directo | 2025 |
| Bhupathiraju S Raju | ED / WTD / CFO / Promoter | 2025 |
| Gaddam Venkata Ramana | ED / MD / Promoter | 2025 |
| Alluri Ranga Raju | Non Executive Director | 2025 |
| Hari Priya Yerukalapudi | Independent Non Exe. Director | 2025 |
| Ramesh Kumar Bandari | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Manufacture of Drug Intermediates & | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹75 Cr | 100% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 11 | 11 | 9 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 1 | 79 | 80 |
| 2025 | 0 | 0 | 0 | 1 | 41 | 43 |
| 2025 | 0 | 0 | 0 | 0 | 38 | 38 |
Insider / Designated-Person Trades
30 recent disclosure(s)
Alluri MaithiliDisposal · 20,000
Alluri Ranga RajuDisposal · 11,600
Pericharla Kishore RajuDisposal · 3,500
Alluri Anantha LaxmiDisposal · 10,000
Alluri Srinivasa RajuDisposal · 5,000
Gaddam Venkata RamanaDisposal · 61,070
Substantial Acquisitions (SAST)
1 disclosure(s)
Rights Issue02/02/2026 · 21,80,000
Company Information
Incorporated2016
ChairmanDilip V Acharekar
AuditorNSVR & Associates LLP
Investor Email[email protected]
📍 SyNo 11/A3 Saheb Nagar KurduVi, Chintal Kunta Eshwaramma LB Nr, Hyderabad, Telangana, 500074
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search